In as little as two years, Americans could be biting into their first gene-edited burgers, courtesy of the U.S. Food and Drug Administration's (FDA) regulatory clearance of gene-edited cattle.

The animals, created by bioengineering company Recombinetics, have genes modified to make their coats shorter and slicker.

The genetic modification to their coats is intended to help them better withstand heat stress, allowing them to gain more weight and increase the efficiency of meat production — but at what cost?

While a lengthy approval process is typically necessary for gene-edited animals to enter the food market, the FDA streamlined the process for gene-edited cattle, allowing them to skirt the regular approval process.

In an interview dropped on Twitter this week, Prof. Talia Geva revealed why she and her colleagues resigned from Israel's Helsinki Committee in January 2020, raising questions about Israel's medical experimentation practices.

The Helsinki Committee is a medical watchdog whose purpose is to "authorize medical research and trials on humans, which aim to expand medical knowledge and improve the outcomes of medical treatment."

Moderna will seek emergency authorization for its Covid-19 vaccine in children under six, the company announced Wednesday, meaning that this age demographic will likely soon be eligible for the shot.

The pharmaceutical company's U.S. and Canadian clinical trial produced promising results, namely that two low doses provided a "robust" immune response in young kids and are safe to be administered, the company said.

There were about 4,200 children subjects in the study between two and six years old and around 2,500 children between six months and two years old. The trial has not been peer-reviewed, Forbes noted.

• Pfizer has recalled the blood pressure drug Accuretic, among others, after discovering nitrosamine impurities
• High levels of nitrosamine have been linked to multiple types of cancer after being exposed to high levels after long periods of time
• Nitrosamine can be common in some process foods, along with goods like cigarettes and makeup, and low levels are safe for humans
• The compound is often formed unintentionally as a result of a reaction between chemicals used in manufacturing and processing of goods

Three blood pressure medications manufactured by the pharmaceutical giant Pfizer have been recalled after a potential cancer-causing chemical compound was discovered in them.

Accuretic, along with two generic blood pressure medications licensed by the company, were found to have elevated levels of nitrosamine, which can put someone at risk of cancer if they are exposed to elevated levels.

The Food and Drug Administration (FDA) reports that some levels of the compounds are ok, and frequent in food and drink consumed everyday, but consistent use of drugs with detected impurities can prove dangerous.

Pfizer voluntarily issued the recall on Monday and did not report any adverse events related to the impurities. The company's Canadian branch recalled another blood pressure drug, Inderal, for similar reasons last week.

Trudeau's Government are trying to cover it up

An investigation of official Government of Canada data has revealed that the fully vaccinated account for 9 in every 10 Covid-19 cases, and 7 in every 10 Covid-19 hospitalisations and deaths across Canada in the most recent wave of infections to hit the country.

This is despite just 6 in every 10 people in Canada being fully vaccinated; suggesting the Covid-19 injections do not only fail to work, they actually make recipients worse.

The Government of Canada is publishing its official Covid-19 data in a way that makes it appear Canada is very much experiencing a 'Pandemic of the Unvaccinated', and that the Covid-19 vaccines are clearly effective.

But the appearance of this data is a fraud, and it is extremely misleading, because by digging deeper we actually find that Canada is very much in the midst of a 'Pandemic of the Fully Vaccinated' and it is unfortunately getting worse by the week.

Evidence-based medicine has been corrupted by corporate interests, failed regulation and commercialisation of academia, which act to suppress negative trial results, conceal adverse events and withhold raw data from the academic research community, according to a peer-reviewed article in the British Medical Journal by Jon Jureidini of the University of Adelaide and Leemon B. McHenry of California State University.

This past weekend, transgender Lia Thomas won the NCAA title in the women's 500-yard freestyle swim, the first transgender athlete to do so. It marks a turning point when a number of people "realised politically correct monsters who don't give a damn about anything other than advancing a hard left ideology are perilously close to wiping out women's sport for good," to quote Dan Wootton.

Seeing Lia on the first place platform, towering over the second and third place competitors, one is struck by a very simple truth - this isn't fair. Biological men, with their myriad physical advantages, should not be able to compete against women for women's athletic titles. Women are losing championships, scholarships and in some cases, getting injured, as they're forced to compete against men.

If this continues, many are saying this will be the end of women's sports. Why would any athletic team not replace all biological female athletes with biological men if it meant securing a win? And with more and more trans-women being allowed to enter women's sports, how is a biological woman supposed to compete?

Join us on this episode of Objective:Health as we talk about the controversial topic of trans-women in women's sports.


And check us out on Brighteon!

For other health-related news and more, you can find us on:

♥Twitter: https://twitter.com/objecthealth
♥Facebook: https://www.facebook.com/objecthealth/
♥Brighteon: https://www.brighteon.com/channel/objectivehealth
♥LBRY: https://lbry.tv/@objectivehealth:f
♥Odysee: https://odysee.com/@objectivehealth:f

And you can check out all of our previous shows (pre YouTube) here:

♥https://docs.google.com/spreadsheets/d/16H-nK-N0ANdsA5JFTT12_HU5nUYRVS9YcQh331dG2MI/edit?usp=sharing

Running Time: 00:37:07

Download: MP3 — 34 MB

Someone once said to me that I really must despise the pharmaceutical industry. There are certainly times when this is true, and my anger with them is sharp ... and hot.

But yet, and yet, I know many people who work in the industry, and they all seem nice, concerned about the world, caring. Trying to do good. The industry itself has also produced some great innovations and medications. Without which the world would be a much scarier and more unpleasant place.

In truth, I find the industry is a bit like capitalism. Both fantastic and dreadful. Which is a bit like humanity itself. Both fantastic and dreadful. Capable of the most amazing things, yet the darker side can be very dark indeed. Dr Jekyll and Mr Hyde.

To be frank, my personal problems with the pharmaceutical industry have mainly centred around cholesterol lowering. Various companies have made billions, nay tens of billions, nay hundreds of billions, pushing LDL-Cholesterol reduction with all their might.

However, I have oft sat with my head in my hands in despair at such nonsense. Pfizer with Lipitor (atorvastatin) pushed the hardest and made the most ... and horribly distorted the entire world of cardiovascular disease research in so doing.

However, thirty years ago, and purely by chance, the planets Pfizer and Kendrick were in a strange alignment. Briefly, I found myself on the same side as Pfizer when it came to cardiovascular disease.

How could this possibly be so? Well, gentle reader, let me take you back to a time when Pfizer had a very different drug to promote, called Doxazocin. It was a type of blood pressure lowering agent known as an Alpha-1 blocker. It was not selling terribly well, so they were looking for other angles in an attempt to boost sales.

I should mention that this was before Pfizer had a statin. A time that you could refer to as the 'BS' era. (Or maybe we are now in the true BS era - discuss). Then, in the year 2000, Pfizer took over Warner Lambert, which just happened to have a statin called atorvastatin (Lipitor). Yes, Pfizer didn't actually develop atorvastatin. They just bought out the company that did. Nifty move.

Anyway, in 1992, Pfizer was not much interested in lowering LDL-Cholesterol, as they didn't have a statin. Which meant they had other fish to fry with their cardiovascular drugs. They were more focused on blood pressure lowering. But their Alpha-1 blocker for this, doxazocin (Cardura) was a bit rubbish.

So, what to do? What to do indeed. What they did was to use the tried and trusted mechanisms of looking at different effects that this drug might have.

China has moved a step closer to developing a home-grown mRNA vaccine against Covid-19, with the publication of early trial results for its prime candidate ARCoV.

No serious adverse events were recorded in the phase 1 clinical trial data, published last week by The Lancet Microbe, but scientists said it was too early to judge its success.

Large-scale trials of the vaccine - jointly developed by the Academy of Military Science, Walvax Biotechnology and Suzhou Abogen Biosciences - have been delayed since last year. No reason was given by the company, though it has become generally more difficult to recruit unvaccinated volunteers for phase 3 trials.

The spike protein pokes holes in cell membranes at concentrations much lower than those achieved with vaccination, contributing to COVID-like illness and mitochondrial damage. But is the J&J immune?